Incretin-based therapy in combination with basal insulin: a promising tactic for the treatment of type 2 diabetes.

Abstract:

:Incretin therapies such as dipeptidyl peptidase-4 inhibitors (DPP-4Is) and GLP-1 receptor agonists (GLP-1RAs) have become well-established treatments for type 2 diabetes. Both drug classes reduce blood glucose through physiological pathways mediated by the GLP-1 receptor, resulting in glucose-dependent enhancement of residual insulin secretion and inhibition of glucagon secretion. In addition, the GLP-1RAs reduce gastrointestinal motility and appear to have appetite-suppressing actions and, so, are often able to produce clinically useful weight loss. The glucose-dependency of their glucagon-inhibiting and insulin-enhancing effects, together with their weight-sparing properties, make the incretin therapies a logical proposition for use in combination with exogenous basal insulin therapy. This combination offers the prospect of an additive or synergistic glucose-lowering effect without a greatly elevated risk of hypoglycaemia compared with insulin monotherapy, and any insulin-associated weight gain might also be mitigated. Furthermore, the incretin therapies can be combined with metformin, which is usually continued when basal insulin is introduced in type 2 diabetes. Although the combination of incretin and insulin therapy is currently not addressed in internationally recognized treatment guidelines, several clinical studies have assessed its use. The data, summarized in this review, are encouraging and show that glycaemic control is improved and weight gain is limited or reversed (especially with the combined use of GLP-1RAs and basal insulin), and that the use of an incretin therapy can also greatly reduce insulin dose requirements. The addition of basal insulin to established incretin therapy is straightforward, but insulin dose adjustment (though not discontinuation) is usually necessary if the sequence is reversed.

journal_name

Diabetes Metab

journal_title

Diabetes & metabolism

authors

Vora J,Bain SC,Damci T,Dzida G,Hollander P,Meneghini LF,Ross SA

doi

10.1016/j.diabet.2012.08.002

subject

Has Abstract

pub_date

2013-02-01 00:00:00

pages

6-15

issue

1

eissn

1262-3636

issn

1878-1780

pii

S1262-3636(12)00120-6

journal_volume

39

pub_type

杂志文章,评审
  • Role of the autonomic nervous system in activation of human brown adipose tissue: A review of the literature.

    abstract::Brown adipose tissue (BAT) is able to convert calories into heat rather than storing them. Therefore, activated BAT could be a potential target in the battle against obesity and type 2 diabetes. This review focuses on the role of the autonomic nervous system in the activation of human BAT. Although the number of studi...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/j.diabet.2015.08.005

    authors: Bahler L,Molenaars RJ,Verberne HJ,Holleman F

    更新日期:2015-12-01 00:00:00

  • Family history of diabetes is associated with enhanced adipose lipolysis: Evidence for the implication of epigenetic factors.

    abstract:AIMS:Type 2 diabetes is associated with insulin resistance, adipose hypertrophy and increased lipolysis. The heritability of these traits has been determined by associating them with a family history of diabetes. METHODS:Abdominal subcutaneous fat biopsies were obtained from 581 subjects in a cross-sectional study. Fa...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2017.10.010

    authors: Dahlman I,Ryden M,Arner P

    更新日期:2018-03-01 00:00:00

  • Osteoprotegerin levels are associated with liver fat and liver markers in dysmetabolic adults.

    abstract:AIM:This study aimed to determine the association between visceral adipose tissue (VAT), liver fat (LF) content, and other markers of the metabolic syndrome (MetS) and osteoprotegerin (OPG) in dysmetabolic adults. METHODS:Subjects from the NUMEVOX cohort were included if they fulfilled at least one MetS criterion. The...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2016.02.004

    authors: Monseu M,Dubois S,Boursier J,Aubé C,Gagnadoux F,Lefthériotis G,Ducluzeau PH

    更新日期:2016-11-01 00:00:00

  • The DECODE study. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe.

    abstract::The current criteria for the diagnosis of diabetes used in France are now based on those published by the American Diabetes Association in 1997: fasting plasma glucose >/= 7.0 mmol/l (126 mg/dl) (previously >/= 7.8 mmol/l (140 mg/dl)), 2-hour glucose >/= 11.1 mmol/l (200 mg/dl) following a 75g oral glucose tolerance t...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:

    authors: Balkau B

    更新日期:2000-09-01 00:00:00

  • Temporary multiple cranial nerve palsies in a patient with type 1 diabetes mellitus.

    abstract::Remittent isolated palsy of peripheral or of upper cranial nerves in diabetic patients is well documented, but paralysis of a lower cranial nerve or an isolated branch of any cranial nerve has rarely been reported. In the case described, besides temporary hypoglossal and facial nerve palsies previously, unilateral tem...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:

    authors: Semiz S,Fişenk F,Akçurin S,Bircan I

    更新日期:2002-11-01 00:00:00

  • Determination of HbA1c concentrations in patients with acute myocardial infarction: comparison of the DCA 2000 device with the HPLC method.

    abstract:BACKGROUND:Recent studies suggest that HbA1c is an important predictor of the glycometabolic state of patients admitted for acute myocardial infarction (AMI). OBJECTIVE:We aimed at comparing the results of HbA1c concentrations obtained by 2 different methods in patients with AMI. RESEARCH DESIGN AND METHODS:In a firs...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/s1262-3636(07)70196-9

    authors: Hadjadj S,Duengler F,Barriere M,Mauco G,Coisne D,Warnier F,Sosner P,Torremocha F,Herpin D,Marechaud R

    更新日期:2005-06-01 00:00:00

  • Inhibitory role of oxytocin on TNFα expression assessed in vitro and in vivo.

    abstract:AIM:Oxytocin administration to diet-induced obese (DIO) rodents, monkeys and humans decreases body weight and fat mass with concomitant improvements in glucose metabolism. Moreover, several studies show an immunomodulatory role of oxytocin in a number of settings (such as atherosclerosis, injury, sepsis). This study ai...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2017.10.004

    authors: Garrido-Urbani S,Deblon N,Poher AL,Caillon A,Ropraz P,Rohner-Jeanrenaud F,Altirriba J

    更新日期:2018-06-01 00:00:00

  • Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).

    abstract:AIM:The best way to treat pregnant patients who have type 1 diabetes is still unclear. For this reason, the present study compared metabolic control and maternal-fetal outcomes in patients treated with continuous subcutaneous infusions of rapid-acting insulin analogues (CSII) or with insulin glargine and multiple daily...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.diabet.2011.02.002

    authors: Bruttomesso D,Bonomo M,Costa S,Dal Pos M,Di Cianni G,Pellicano F,Vitacolonna E,Dodesini AR,Tonutti L,Lapolla A,Di Benedetto A,Torlone E,Italian Group for Continuous Subcutaneous Insulin Infusion in Pregnancy.

    更新日期:2011-11-01 00:00:00

  • Trajectories of fasting plasma glucose variability and mortality in type 2 diabetes.

    abstract:AIM:To investigate the effect of changes in fasting plasma glucose (FPG) variability, as assessed by 2-year trajectories of FPG variability, on mortality risk in patients with type 2 diabetes (T2D). METHODS:From 2009 to 2012, outpatients with T2D, aged>18 years, were enrolled from a medical centre. FPG was measured ev...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2017.09.001

    authors: Lee CL,Sheu WH,Lee IT,Lin SY,Liang WM,Wang JS,Li YF

    更新日期:2018-03-01 00:00:00

  • Association between metabolically unhealthy overweight/obesity and chronic kidney disease: the role of inflammation.

    abstract:AIM:Our study explored the association between subtypes of increased fat mass (with or without associated metabolic alterations) and the presence of chronic kidney disease (CKD). METHODS:In this cross-sectional survey in China, body mass index (BMI) was used to assess fat mass. Metabolically healthy was defined as no ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2014.08.005

    authors: Chen S,Zhou S,Wu B,Zhao Y,Liu X,Liang Y,Shao X,Holthöfer H,Zou H

    更新日期:2014-12-01 00:00:00

  • Expression of a thioredoxin peroxidase in insulin-producing cells.

    abstract::The presence of thioredoxin peroxidase (TPx), also known as thiol specific antioxidant (TSA), was investigated in neonatal and adult rat islets, and in the beta-cell line HIT-T15. Western blotting of extracts from neonatal and adult pancreatic islets and from the tumoral cell line HIT-T15 revealed the presence of a 25...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:

    authors: Boschero AC,Stoppiglia LF,Collares-Buzato CB,Bosqueiro JR,Delghingaro-Augusto V,Leite A,Carvalho CP,Netto LE,Carneiro EM

    更新日期:2002-12-01 00:00:00

  • [The insulin sensitivity concept].

    abstract::Insulin resistance was already suspected in the thirties from clinical observations in diabetic patients, then better appreciated in the early sixties with the development of insulin radioimmunoassay, and finally confirmed in the last 20 years by using various sophisticated methods able to quantify insulin action. Fir...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:

    authors: Scheen AJ

    更新日期:2001-04-01 00:00:00

  • Serum fructosamine predicts macrosomia in well-controlled hyperglycaemic pregnant women: An observational cross-sectional study.

    abstract:AIM:While serum fructosamine may be a good marker of glucose control in pregnant women with diabetes, its relationship with macrosomia is still uncertain. METHODS:In 130 hyperglycaemic women with singleton pregnancies (117 gestational diabetes mellitus, 13 pregestational diabetes), serum fructosamine and HbA1c levels ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2019.07.003

    authors: Poupon P,Foussard N,Helmer C,Cougnard-Gregoire A,Rajaobelina K,Delcourt C,Lamireau T,Haissaguerre M,Blanco L,Alexandre L,Mohammedi K,Rigalleau V

    更新日期:2020-06-01 00:00:00

  • Glycaemic variability is associated with severity of coronary artery disease in patients with poorly controlled type 2 diabetes and acute myocardial infarction.

    abstract:BACKGROUND:In patients with type 2 diabetes (T2D), glycaemic variability (GV), another component of glycaemic abnormalities, is a novel potentially aggravating factor for coronary artery disease (CAD). OBJECTIVES:The aim of our study was to identify interactions between GV and severity of CAD in diabetes patients admi...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2019.01.012

    authors: Benalia M,Zeller M,Mouhat B,Guenancia C,Yameogo V,Greco C,Yao H,Maza M,Vergès B,Cottin Y

    更新日期:2019-10-01 00:00:00

  • IL-33 receptor ST2 deficiency attenuates renal ischaemia-reperfusion injury in euglycaemic, but not streptozotocin-induced hyperglycaemic mice.

    abstract:AIM:Kidney hypoxia can predispose to the development of acute and chronic renal failure in diabetes. Ischaemia-reperfusion injury (IRI) causes inflammation, and diabetes is known to exacerbate this inflammatory response in the kidney, whereas alarmin IL-33 could act as an innate immune mediator during kidney IRI. Thus,...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2017.06.008

    authors: Sehnine M,Ferhat M,Sena S,Gombert JM,Goujon JM,Thierry A,Touchard G,Hauet T,Herbelin A,Hadjadj S

    更新日期:2018-02-01 00:00:00

  • Fetal macrosomia and maternal weight gain during pregnancy.

    abstract:BACKGROUND:To calculate an adjusted maternal weight gain during pregnancy including infant and placental weights to the actual weight gain and secondarily examine its influence on the occurrence of fetal macrosomia. METHODS:The corrected weight gain was calculated as follows: maternal body weight at the last prenatal ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:

    authors: Lepercq J,Hauguel-De Mouzon S,Timsit J,Catalano PM

    更新日期:2002-09-01 00:00:00

  • Serum levels of osteopontin predict diabetes remission after bariatric surgery.

    abstract:AIM:Bariatric surgery has been shown to effectively improve glycaemic control in morbidly obese subjects. However, the molecular bases of this association are still elusive and may act independently of weight loss. Here, our retrospective study has investigated the inflammatory molecule osteopontin (OPN) as a potential...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2018.09.007

    authors: Carbone F,Adami G,Liberale L,Bonaventura A,Bertolotto M,Andraghetti G,Scopinaro N,Camerini GB,Papadia FS,Cordera R,Dallegri F,Montecucco F

    更新日期:2019-09-01 00:00:00

  • Blood glucose changes and adjustments of diet and insulin doses in type 1 diabetic patients during scuba diving (for a change in French regulations).

    abstract:OBJECTIVE:In France, diabetic subjects were not allowed to dive. The principal risk is hypoglycemia during immersion. However scuba diving is allowed in many countries. To follow blood glucose changes, food intake and insulin adjustments in type 1 diabetic patients when diving, and to propose specific guidelines for su...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/s1262-3636(07)70180-5

    authors: Lormeau B,Sola A,Tabah A,Chiheb S,Dufaitre L,Thurninger O,Bresson R,Lormeau C,Attali JR,Valensi P

    更新日期:2005-04-01 00:00:00

  • Diabetes and cognitive impairment: how to evaluate the cognitive status?

    abstract:AIM:Patients with diabetes have shown lower performance in tests of cognitive function especially those testing memory, executive functions, and psychomotor efficiency. They also have an elevated risk of both vascular dementia and Alzheimer's disease. Cognitive impairment may have consequence on treatment compliance. ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/S1262-3636(10)70475-4

    authors: Pasquier F

    更新日期:2010-10-01 00:00:00

  • Bariatric surgery in young massively obese diabetic patients.

    abstract::Obesity is the most important lifestyle-related risk factor for type 2 diabetes (T2DM). The prevalence of T2DM in adolescents is increasing in parallel with the increasing incidence of major obesity. In adult obese subjects, the greatest degree of T2DM prevention, improvement or recovery has been reported in patients ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/S1262-3636(09)73462-7

    authors: Ciangura C,Basdevant A

    更新日期:2009-12-01 00:00:00

  • Effectiveness of patient education on glycemic control in insulin treated patients in general practice.

    abstract:OBJECTIVE:To assess the effectiveness of a patient education program on diabetes control. METHODS:A pre-test post-test pre experimental study was performed with 87 insulin treated diabetic patients followed in the chronic disease unit of Kelibia district (Nabeul, Tunisia). Subjects received education in 6 monthly sess...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/s1262-3636(07)70207-0

    authors: Jenhani M,Gaha K,Nabouli R,Ghedira A,Ben Abdelaziz A

    更新日期:2005-09-01 00:00:00

  • Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography.

    abstract:AIM:Recent prospective studies have identified distinct plasma ceramides as strong predictors of major adverse cardiovascular events in patients with established or suspected coronary artery disease (CAD). Currently, it is uncertain whether higher levels of distinct plasma ceramides are associated with greater angiogra...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2019.07.006

    authors: Mantovani A,Bonapace S,Lunardi G,Canali G,Dugo C,Vinco G,Calabria S,Barbieri E,Laaksonen R,Bonnet F,Byrne CD,Targher G

    更新日期:2020-04-01 00:00:00

  • [From external to implantable insulin pump, can we close the loop?].

    abstract::The project to finalize a 'closed loop' insulin delivery according to blood glucose level, i.e. an implanted artificial beta cell, is born from the development of the first miniaturized portable insulin pumps during the 1970s. Continuous improvements in micro-electronics, as well as in the development of biomaterials ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:

    authors: Renard E,Costalat G,Bringer J

    更新日期:2002-09-01 00:00:00

  • Evaluation of the locus of control in patients with type 2 diabetes after long-term management by group care.

    abstract:AIM:To investigate the locus of control in patients with type 2 diabetes followed by systemic group education (Group Care) and traditional one-to-one care. METHODS:In a post-hoc analysis, two questionnaires were administered to 56 patients who had been followed for 5-7 years by Group Care and 51 controls followed by i...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/s1262-3636(07)70250-1

    authors: Trento M,Passera P,Miselli V,Bajardi M,Borgo E,Tomelini M,Tomalino M,Cavallo F,Porta M

    更新日期:2006-02-01 00:00:00

  • Type 2 diabetes treatment intensification in general practice in France in 2008-2009: the DIAttitude Study.

    abstract:AIMS:To evaluate the current procedures in French general practice of intensifying hypoglycaemic treatment in orally treated type 2 diabetic patients, according to the French recommendations. METHODS:Type 2 diabetic patient characteristics, HbA(1c) values, hypoglycaemic treatment and physician characteristics were col...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/S1262-3636(12)71532-X

    authors: Balkau B,Bouée S,Avignon A,Vergès B,Chartier I,Amelineau E,Halimi S

    更新日期:2012-03-01 00:00:00

  • Measuring insulin sensitivity in youth: How do the different indices compare with the gold-standard method?

    abstract:AIM:The objective of the study was to examine the correlation between three methods of measuring insulin sensitivity (IS) - namely, the frequently sampled intravenous glucose tolerance test (FSIVGTT), indices derived from the oral glucose tolerance test (OGTT) and fasting indices (HOMA-IR, QUICKI, fasting insulin [INS(...

    journal_title:Diabetes & metabolism

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.diabet.2010.06.008

    authors: Henderson M,Rabasa-Lhoret R,Bastard JP,Chiasson JL,Baillargeon JP,Hanley JA,Lambert M

    更新日期:2011-02-01 00:00:00

  • Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: results from the randomized Optima study.

    abstract:AIM:To compare continuous glucose monitoring (CGM) profiles on vildagliptin versus sitagliptin in addition to metformin, in patients with inadequately controlled type 2 diabetes mellitus (HbA(1c) 6.5-8.0%). METHODS:A multicenter, prospective, randomised, open-label study with blinded endpoint analysis. CGM data acquir...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.diabet.2012.06.001

    authors: Guerci B,Monnier L,Serusclat P,Petit C,Valensi P,Huet D,Raccah D,Colette C,Quéré S,Dejager S

    更新日期:2012-10-01 00:00:00

  • A randomised study evaluating the effects of cisapride on glucose variability and quality of life parameters in insulin-dependent diabetes mellitus patients.

    abstract::This study evaluated the effect of cisapride on glycaemic control, well-being and treatment satisfaction in insulin-dependent diabetes mellitus (IDDM) patients with documented moderate to severe glycaemic instability. Thirty-seven patients with glycaemic instability were included in a randomized, double-blind, placebo...

    journal_title:Diabetes & metabolism

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Johansson UB,Wredling RA,Adamson UC,Lins PE

    更新日期:1999-09-01 00:00:00

  • Adiponectin is expressed in the pancreas of high-fat-diet-fed mice and protects pancreatic endothelial function during the development of type 2 diabetes.

    abstract:AIM:Adiponectin levels in skeletal muscle and adipose tissue have been reported to be involved in insulin resistance in rats fed with a high-fat diet (HFD). Our objective was to explore whether adiponectin is also expressed in the pancreas and what its potential role is during the development of type 2 diabetes (T2D) i...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2014.05.004

    authors: Liu XX,Liu KY,Li P,Han S,Peng XD,Shen L

    更新日期:2014-11-01 00:00:00

  • A new challenge for diabetologists and geriatricians!

    abstract::The "Société Française de Gériatrie et Gérontologie" (SFGG) and "Association de Langue Française pour l'Etude du Diabète et des Maladies Métaboliques" (ALFEDIAM) have decided to join their efforts in actions to improve the management and treatment of the elderly diabetic patients. New knowledge brought by the fundamen...

    journal_title:Diabetes & metabolism

    pub_type: 社论

    doi:10.1016/s1262-3636(05)73646-6

    authors: Tréton J

    更新日期:2005-12-01 00:00:00